Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc.

Bullboard Posts

Post by investright12on Nov 12, 2019 8:04am

80 Views

Post# 30338783

AMG needs to be sued

Either buy hold or sell the stock..If you dont like it no one is forcing you to buy it. IF you think AGN was sold at too low a price, you could have loaded up as it was a free offering thru Mackie open to ANYONE.

You post allot of accussations that a business person should take to court and clean your clock..simply sell and move on if you dont lilke this group and have a better group to go to..you obviously dont

Bullboard Posts

Full Circle Lithium goes global with its battery fire-fighter